$FRST Cashflow Statement | Understand Stock

$FRST

$14.82 -$0.02 (0.13%) Close

$FRST Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of cash flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Operating activities:
Net income (loss) from continuing operations
Net income
Adjustments to reconcile net income (loss) to net cash and cash equivalents provided by operating activities:
Depreciation and amortization
Amortization of operating lease right-of-use assets
Net amortization of premiums and (accretion of discounts)
Provision for (recovery of) credit losses
Provision for credit losses
Origination of loans held for sale
Proceeds from sale of loans held for sale
Proceeds from sales of loans
Proceeds from sales of loans originated to sell
Purchases of cloud computing arrangement assets
Net change in mortgage loans held for sale
Net gains on mortgage banking
Net gains on sale of loans
Loss (gain) on bank premises and equipment and assets held for sale
Earnings on bank-owned life insurance
Gain on bank-owned life insurance death benefit
Stock-based compensation expense
Loss on other real estate owned
Gain on debt extinguishment
Gain on sale-leaseback of bank premises
Loss on sales of investment securities
Gains on Panacea Financial Holdings investment
Gains on other investments
Credit enhancement income
Gain on sale of Life Premium Finance portfolio, net of broker fees
Goodwill impairment
Deferred income tax expense (benefit)
Net change in fair value of Consumer Program derivative
Net decrease (increase) in other assets
Net increase (decrease) in other liabilities

Net cash and cash equivalents provided by operating activities
Investing activities:
Proceeds from sales of securities held-to-maturity
Proceeds from sales of securities available-for-sale
Purchases of securities held-to-maturity
Proceeds from sales of investment securities
Purchases of securities available-for-sale
Proceeds from paydowns, maturities and calls of securities available-for-sale
Proceeds from paydowns, maturities and calls of securities held-to-maturity
Net (increase) decrease in FRB and FHLB stock
Net change in loans held for investment
Proceeds from sales of loans initially originated to be held for investment
Proceeds from bank-owned life insurance death benefit
Proceeds from sales of other real estate owned, net of improvements
Proceeds from sales of bank premise and equipment and assets held for sale
Proceeds from sale-leaseback of bank premises
Purchases of bank premises and equipment, net
Proceeds from sale of Panacea Financial Holdings investment
Proceeds from sale of other investment
Business acquisition, net of cash acquired
Net decrease (increase) in other investments
Net cash and cash equivalents (used in) provided by investing activities

Financing activities:
Net increase (decrease) in deposits
(Decrease) increase in securities sold under agreements to repurchase
(Repayments of) increases in secured borrowings, net
Repayment of short-term FHLB advances
Repayment of short-term borrowings
Cash dividends paid on common stock
Repurchase of common stock
Proceeds from exercised stock options
Repurchase of restricted stock
Issuance of subordinated notes, net of cost
Extinguishment of senior subordinated notes
Repayment of FHLB advances, long-term
Proceeds from short-term FHLB advances, net of repayments
Increase in short-term FHLB advances
Other net changes in noncontrolling interest
Issuance of Panacea Financial Holdings stock, net of costs
Increase in secured borrowings
Net cash and cash equivalents provided by (used in) financing activities

Net change in cash and cash equivalents from continuing operations
Net cash and cash equivalents used in operating activities
Net cash and cash equivalents provided by investing activities
Net change in cash and cash equivalents from discontinued operation
Net change in cash and cash equivalents
Cash and cash equivalents at beginning of period
Cash and cash equivalents at end of period
Supplemental disclosure of cash flow information
Cash payments (receipts) for:
Interest
Income taxes
Supplemental schedule of noncash activities:
Initial recognition of operating lease right-of-use assets
Loans held for sale transferred to held for investment
Loans held for investment transferred to loans held for sale, at lower of cost or market
Assets held for sale transferred to other assets
Shares issued in lieu of cash bonus
Proceeds from sale of other investment included in other assets
Proceeds from bank-owned life insurance death benefit included in other assets
Transfer from loans to other real estate owned
Notes receivable from discontinued operation, included in loans
Fair value of tangible assets acquired
Other intangible assets acquired
Fair value of liabilities assumed
Total merger consideration, net of $2,446 of cash acquired
Deconsolidation of Panacea Financial Holdings, Inc.

Comments